Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.28 - $0.75 $6,935 - $18,576
24,769 Added 40.17%
86,425 $30,000
Q4 2022

Feb 13, 2023

SELL
$0.54 - $21.75 $86 - $3,480
-160 Reduced 0.26%
61,656 $41,000
Q2 2022

Aug 12, 2022

BUY
$6.1 - $7.15 $17,580 - $20,606
2,882 Added 4.89%
61,816 $66,000
Q3 2021

Nov 12, 2021

BUY
$8.02 - $11.0 $64,753 - $88,814
8,074 Added 15.87%
58,934 $310,000
Q2 2021

Aug 13, 2021

BUY
$7.59 - $10.48 $227,366 - $313,938
29,956 Added 143.3%
50,860 $301,000
Q1 2021

May 12, 2021

BUY
$6.86 - $9.24 $143,401 - $193,152
20,904 New
20,904 $148,000

About Cyclacel Pharmaceuticals, Inc.


  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $4.64M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.